Outsourcing No Longer Optional?!
I came across this article and think there may be a point to it. The authors claim that outsourcing in the pharmaceutical industry is no longer an option but a necessity.
BMS claims outsourcing no longer an option
While there is some truth to this, it also ignores what would happen if there is a down-turn in the industry or if a major problem should happen at a contract manufacturer. Although I hope it doesn’t happen, if such an event would occur, it would definitely have a major impact on the industry. Also, I think if major pharma companies have an excess of capacity, they won’t outsource but keep it in-house.
I firmly believe that outsourcing is indeed important but I don’t share the opinion that it is no longer optional. The choice to outsource should be made carefully and with a eye on what is important. not all activities can or should be outsourced. Outsourcing of activities that bring an added value to the company are ones that are prime candidates for outsourcing.
Technorati Tags: Bristol-Myers Squibb, drug development, outsourcing
Related Posts:
Bookmark it with:
| 
del.icio.us
| 
Digg it
| 
Furl
| 
Simpy
| 
Spurl
| 
My Yahoo!
|
